Finance Watch: VC Mega-Rounds Make A Comeback In March

After what seemed like a relatively quiet stretch for venture capital mega-rounds of $100m or more, the pace of large VC financings has picked up in March with five big rounds announced already this month, led by a $200m series A for CARGO Therapeutics, Inc., which launched on 1 March to develop next-generation chimeric antigen receptor T-cell (CAR-T) therapies, including a Phase II-ready asset.

Venture capital investors raised billions of dollars during the past few years for biopharma opportunities, but many slowed the pace of their investment in 2022, a trend that continued into...